FOLH1 and renal cell carcinoma: In the literature, the semi-quantitative PSMA PET/CT parameters of both RCC and ccRCC lesions located in the kidneys seems to be higher for radiopharmaceuticals mainly excreted by the kidneys than for those excreted via the liver route.